Advanced BRAF Mutant Cancers Terminated Phase 1 / 2 Trials for Sonolisib (DB12601)

Also known as: Advanced BRAF-mutant Cancers

IndicationStatusPhase
DBCOND0117671 (Advanced BRAF Mutant Cancers)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01616199Study of PX-866 and Vemurafenib in Patients With Advanced MelanomaTreatment